1. DoRA 2.0 | Database of Research Activity
  2. Hospital and Health Services
  3. Children's Health Queensland
  4. Children's Health Queensland Publications
Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/4231
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLopez, R. N.en
dc.contributor.authorDay, A. S.en
dc.date.accessioned2022-11-07T23:50:41Z-
dc.date.available2022-11-07T23:50:41Z-
dc.date.issued2020en
dc.identifier.citation56, (11), 2020, p. 1719-1723en
dc.identifier.otherRISen
dc.identifier.urihttp://dora.health.qld.gov.au/qldresearchjspui/handle/1/4231-
dc.description.abstractPrimary intestinal lymphangiectasia is an uncommon condition that usually presents early in childhood. This incurable condition is consequent to underlying lymphatic abnormalities that lead to loss of lymphatic contents into the intestinal lumen. This article outlines an approach to the assessment of children presenting with characteristic features and consideration of other conditions that could lead to enteric protein loss. An overview of the management of primary intestinal lymphangiectasia is outlined.L20050967262020-06-03 <br />2021-02-03 <br />en
dc.language.isoenen
dc.relation.ispartofJournal of Paediatrics and Child Healthen
dc.titlePrimary intestinal lymphangiectasia in children: A reviewen
dc.typeArticleen
dc.identifier.doi10.1111/jpc.14837en
dc.subject.keywordsdouble balloon enteroscopyen
dc.subject.keywordsdrug administration routeen
dc.subject.keywordsduodenum biopsyen
dc.subject.keywordsfeces levelen
dc.subject.keywordshistopathologyen
dc.subject.keywordshumanen
dc.subject.keywordshypoalbuminemiaen
dc.subject.keywordshypoplasiaen
dc.subject.keywordsimmunoglobulin deficiencyen
dc.subject.keywordsintestine lymphen
dc.subject.keywordsintestine lymphangiectasiaen
dc.subject.keywordsintestine resectionen
dc.subject.keywordsintestine surgeryen
dc.subject.keywordslymphatic systemen
dc.subject.keywordslymphocytopeniaen
dc.subject.keywordspriority journalen
dc.subject.keywordsrandomized controlled trial (topic)en
dc.subject.keywordsreviewen
dc.subject.keywordsvitamin blood levelen
dc.subject.keywordspathophysiologyen
dc.subject.keywordsalbuminalpha 1 antitrypsinen
dc.subject.keywordsantineoplastic agenten
dc.subject.keywordscorticosteroid derivativeen
dc.subject.keywordseverolimusen
dc.subject.keywordsfurosemideen
dc.subject.keywordsheparinen
dc.subject.keywordsimmunoglobulinen
dc.subject.keywordsoctreotideen
dc.subject.keywordsplasmin inhibitoren
dc.subject.keywordssirolimusen
dc.subject.keywordsvitamin Den
dc.subject.keywordscapsule endoscopyen
dc.subject.keywordsclinical featureen
dc.subject.keywordsdiet therapyen
dc.relation.urlhttps://www.embase.com/search/results?subaction=viewrecord&id=L2005096726&from=exporthttp://dx.doi.org/10.1111/jpc.14837 |en
dc.identifier.risid1628en
dc.description.pages1719-1723en
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextNo Fulltext-
item.languageiso639-1en-
item.grantfulltextnone-
item.cerifentitytypePublications-
item.openairetypeArticle-
Appears in Sites:Children's Health Queensland Publications
Show simple item record

Page view(s)

24
checked on Feb 13, 2025

Google ScholarTM

Check

Altmetric


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.